Dirithromycin
From Wikipedia, the free encyclopedia
Dirithromycin
|
|
Systematic (IUPAC) name | |
(1S,2R,4R,5R,6S,7S,8R,11R,12R,15R,17S)- 5-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy- 6-methyl-oxan-2-yl]oxy-11-ethyl-4,12-dihydroxy- 7-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy- 4,6-dimethyl-oxan-2-yl]oxy-15-(2-methoxyethoxymethyl)- 2,4,6,8,12,17-hexamethyl-10,14-dioxa-16- azabicyclo[11.3.1]heptadecan-9-one |
|
Identifiers | |
CAS number | 62013-04-1 |
ATC code | J01FA13 |
PubChem | 5464388 |
DrugBank | APRD00931 |
Chemical data | |
Formula | C42H78N2O14 |
Mol. weight | 835.074 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Dirithromycin is a macrolide glycopeptide antibiotic.
[edit] External links
- Duran D, Aviyente V, Baysal C (2004). "A computational approach to the synthesis of dirithromycin.". J Mol Model (Online) 10 (2): 94-101. PMID 14722740.
- Castaldo R, Celli B, Gomez F, LaVallee N, Souhrada J, Hanrahan J (2003). "A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.". Clin Ther 25 (2): 542-57. PMID 12749513.
- Mazzei T, Surrenti C, Novelli A, Biagini M, Fallani S, Cassetta M, Conti S, Surrenti E (1999). "Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.". Antimicrob Agents Chemother 43 (7): 1556-9. PMID 10390202.
Glycopeptides (J01, and others) edit | ||
---|---|---|
Macrolides: Azithromycin, Clarithromycin, Dirithromycin, Erythromycin, Roxithromycin Others: Aztreonam, Monobactam, Teicoplanin, Vancomycin |